Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Int J Cardiol ; 243: 73-80, 2017 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-28506550

RÉSUMÉ

PURPOSE: Pre and post-operative administration of sevoflurane in myocardial revascularization surgery provides enhanced cardioprotective effects exerted by pharmacologic pre- and post-conditioning, as compared to propofol. The identification of the enzymes involved in conditioning mechanisms is crucial to the understanding of the effects of sevoflurane in cardiac surgery patients. The impact of sevoflurane on another crucial target organ-the kidney-was also assessed. METHODS: Ninety patients undergoing off-pump myocardial revascularization surgery were allocated to receive either intra- and postoperative sevoflurane (SS), intraoperative sevoflurane and postoperative propofol (SP), or intra- and postoperative propofol (PP)). Troponin I and hemodynamic parameters were monitored during the first 48 postoperative hours; blood and urine samples were collected at baseline and at 24h to determine Akt, ERK1/2, PKG, iNO, bradykinin receptor, caspase 3, NT proBNP and urinary NGAL. RESULTS: The enzymes were overexpressed in the SS group, remained unchanged in the SP group, and decreased in the PP group. Renal function was best preserved in the SS group. CONCLUSIONS: The overexpression of enzymes induced by intraoperative anesthesia and postoperative sedation with sevoflurane reduces myocardial damage and improves renal function in patients undergoing off-pump myocardial revascularization surgery.


Sujet(s)
Cardiotoniques/administration et posologie , Maladie des artères coronaires/chirurgie , Éthers méthyliques/administration et posologie , Revascularisation myocardique/méthodes , Antiagrégants plaquettaires/administration et posologie , Propofol/administration et posologie , Sujet âgé , Anesthésiques intraveineux/administration et posologie , Maladie des artères coronaires/traitement médicamenteux , Femelle , Humains , Mâle , Adulte d'âge moyen , Sévoflurane , Résultat thérapeutique
2.
Surg Obes Relat Dis ; 13(3): 442-450, 2017 Mar.
Article de Anglais | MEDLINE | ID: mdl-27986580

RÉSUMÉ

BACKGROUND: Bariatric surgery (BS) is proposed as a highly effective therapy for reducing weight and improving obesity-related co-morbidities. The molecular mechanisms involved in the metabolic improvement after BS are not completely resolved. Epigenetic modifications could have an important role. OBJECTIVE: The aim of this study was to evaluate the effect of different BS procedures (Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy) on global DNA methylation (long interspersed nucleotide element 1 [LINE-1]) in a group of nondiabetic and diabetic severely obese patients. SETTING: University hospital, Spain. METHODS: This study included 60 patients (30 nondiabetic and 30 diabetic severely obese patients) undergoing BS: 31 patients underwent Roux-en-Y gastric bypass and 29 underwent laparoscopic sleeve gastrectomy. Before and 6 months post-BS, anthropometric data, blood pressure, and metabolic parameters were determined. LINE-1 DNA methylation was quantified by pyrosequencing. We used the methylation levels of tumor necrosis factor-α as a control gene promoter. RESULTS: There were no differences between LINE-1 methylation levels at baseline and at 6 months after surgery (66.3±1.6 versus 66.2±2.06). Likewise, there was no statistically significant difference on LINE-1 methylation levels when we stratified according to metabolic status (diabetic versus nondiabetic), nor was there regarding the BS procedure. A strong correlation was shown between LINE-1 methylation levels and weight at baseline both in diabetic and nondiabetic obese patients (r = .486; P<.001). Tumor necrosis factor-α methylation levels increased significantly after BS in the group of diabetic obese patients. CONCLUSION: After BS, global LINE-1 methylation is not modified in the short term. More studies are required to determine if LINE-1 is a stable epigenetic marker, or, on the contrary, if it is susceptible to modification by external factors such as changes in lifestyle or a surgical intervention.


Sujet(s)
Chirurgie bariatrique , Diabète de type 2/génétique , Éléments LINE/génétique , Obésité morbide/génétique , Adulte , Méthylation de l'ADN/génétique , Diabète de type 2/complications , Femelle , Gastrectomie , Dérivation gastrique , Humains , Laparoscopie , Mâle , Obésité morbide/complications , Soins postopératoires , Régions promotrices (génétique)/génétique
3.
J Cardiopulm Rehabil Prev ; 34(1): 43-8, 2014.
Article de Anglais | MEDLINE | ID: mdl-24280905

RÉSUMÉ

PURPOSE: The aim of the study was to determine the effect of lifestyle changes in patients participating in a cardiac rehabilitation program. METHODS: Patients with cardiovascular disease (N = 59) were enrolled in cardiac rehabilitation, which included nutritional and exercise interventions. All patients completed the program, but only 44 attended the reassessment after 12 months because of work reasons or lack of time or interest. RESULTS: Ergometry before and after cardiac rehabilitation showed significant differences in exercise tolerance time (5.2 ± 1.8 minutes vs 7.1 ± 2.1 minutes; P< .001), metabolic equivalents (6.5 ± 1.8 vs 8.8 ± 2.2; P< .001), and the Börg rating of perceived exertion scale (12 ± 1.8 points vs 13.7 ± 1.6 points; P= .005). At the end of the intervention program, significant improvements were seen in body weight (82.6 ± 15.2 kg vs 80.8 ± 14.3 kg; P< .001), waist circumference (100.3 ± 12.4 cm vs 98.0 ± 11.0 cm; P= .002), and levels of fasting glucose (126.5 ± 44.6 mmol/L vs 109.6 ± 24.8 mmol/L; P< .001), low-density lipoprotein cholesterol (2.7 ± 0.9 mmol/L vs 2.5 ± 0.8 mmol/L; P= .033), and C-reactive protein (5.1 ± 8.7 µg/mL vs 4.1 ± 2.6 µg/mL; P= .008), as well as in adherence to a healthy diet as estimated by the Trichopoulou questionnaire score (7.9 ± 2.3 vs 10.6 ± 1.5; P< .001). Twelve months later, however, many of these benefits had either remained stable or worsened. CONCLUSIONS: Cardiac rehabilitation is an appropriate program for the improvement of clinical and analytical variables, such as functional capacity, carbohydrate and lipid metabolism, anthropometric measures, and diet. However, 12 months later, many of these benefits either remained stable or worsened.


Sujet(s)
Maladies cardiovasculaires , Traitement par les exercices physiques/méthodes , Thérapie nutritionnelle/méthodes , Adulte , Sujet âgé , Attitude envers la santé , Réadaptation cardiaque , Maladies cardiovasculaires/métabolisme , Maladies cardiovasculaires/physiopathologie , Maladies cardiovasculaires/psychologie , Ergométrie/méthodes , Femelle , Humains , Mode de vie , Mâle , Adulte d'âge moyen , Monitorage physiologique/méthodes , Évaluation de l'état nutritionnel , , Évaluation de programme , Perte de poids
4.
Oncol Rep ; 31(1): 405-14, 2014 Jan.
Article de Anglais | MEDLINE | ID: mdl-24154820

RÉSUMÉ

Malnutrition affects 40-50% of patients with ear, nose and throat (ENT) cancer. The aim of this study was to assess changes induced by a specific nutritional supplement enriched with n-3 polyunsaturated fatty acids, fiber and greater amounts of proteins and electrolytes, as compared with a standard nutritional supplement, on markers of inflammation, oxidative stress and metabolic status of ENT cancer patients undergoing radiotherapy (RT). Fourteen days after starting RT, 26 patients were randomly allocated to one of two groups, 13 supplemented with Prosure, an oncologic formula enriched with n-3 polyunsaturated fatty acids, fiber and greater amounts of proteins and electrolytes (specific supplement), and 13 supplemented with Standard-Isosource (standard supplement). Patients were evaluated before RT, and 14, 28 and 90 days after starting RT. The results showed that there were no significant differences between the groups, but greater changes were observed in the standard supplement group, such as a decline in body mass index (BMI), reductions in hematocrit, erythrocyte, eosinophil and albumin levels, and a rise in creatinine and urea levels. We concluded that metabolic, inflammatory and oxidative stress parameters were altered during RT, and began to normalize at the end of the study. Patients supplemented with Prosure showed an earlier normalization of these parameters, with more favorable changes in oxidative stress markers and a more balanced evolution, although the difference was not significant.


Sujet(s)
Compléments alimentaires , Tumeurs de l'oreille/complications , Acides gras insaturés/usage thérapeutique , Malnutrition/traitement médicamenteux , Tumeurs du nez/complications , Stress oxydatif/effets des médicaments et des substances chimiques , Tumeurs du pharynx/complications , Antioxydants/métabolisme , Marqueurs biologiques/métabolisme , Indice de masse corporelle , Protéine C-réactive/analyse , Fibre alimentaire/usage thérapeutique , Tumeurs de l'oreille/traitement médicamenteux , Tumeurs de l'oreille/radiothérapie , Électrolytes/usage thérapeutique , Femelle , Glutathione peroxidase/métabolisme , Humains , Peroxyde d'hydrogène/métabolisme , Inflammation/traitement médicamenteux , Interleukine-6/sang , Mâle , Malnutrition/étiologie , Adulte d'âge moyen , Tumeurs du nez/traitement médicamenteux , Tumeurs du nez/radiothérapie , Tumeurs du pharynx/traitement médicamenteux , Tumeurs du pharynx/radiothérapie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...